GlassScriptPhysician profile
Seth Brandon Wenig
NPI 1841678364
$1,851.32
in general payments reported to CMS, 2019-2025
23 companies · $628 in 2025
The $628 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.27 · 2020: $176 · 2021: $138 · 2022: $58.27 · 2023: $181 · 2024: $636 · 2025: $628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,444.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $235.42 | 2023-2025 | Teflaro, Avycaz |
| Mallinckrodt Hospital Products INC. | $229.16 | 2020-2025 | Acthar |
| Inari Medical, INC. | $172.82 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $171.23 | 2021-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $170.17 | 2020-2025 | Ofev |
| Actelion Pharmaceuticals US, INC. | $143.83 | 2023-2025 | Uptravi |
| Csl Behring | $125.00 | 2024 | Kcentra |
| Glaxosmithkline, LLC. | $87.29 | 2019-2025 | Nucala |
| Merck Sharp & Dohme LLC | $68.16 | 2022-2025 | |
| Pfizer INC. | $60.51 | 2023-2025 | |
| Insmed, INC. | $51.89 | 2024-2025 | Arikayce |
| Electromed, INC. | $48.23 | 2025 | Smartvest |
| Paratek Pharmaceuticals, INC. | $47.94 | 2025 | Nuzyra |
| Inogen, INC. | $41.45 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| 3b Medical, INC. | $30.43 | 2025 | Luna |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $27.84 | 2025 | |
| Genentech USA, INC. | $25.00 | 2022 | |
| Shield Therapeutics INC | $23.33 | 2025 | |
| Mylan Specialty L.P. | $22.83 | 2024 | Yupelri |
| Baxter Healthcare | $19.96 | 2024 | Hillrom - Life 2000 Ventilation System |
| Viatris Specialty LLC | $17.62 | 2025 | Yupelri |
| Allergan, INC. | $17.39 | 2020 | |
| Chiesi USA, INC. | $13.82 | 2023 | Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Wenig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.